Fig. 1From: Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreakThe complete workflow for the identification of luteolin and abyssinone II as most potent inhibitors against Mpro/3CLro, PLpro and ACE2 of COVID-19Back to article page
